[go: up one dir, main page]

YU48176B - Novi tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja - Google Patents

Novi tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja

Info

Publication number
YU48176B
YU48176B YU119491A YU119491A YU48176B YU 48176 B YU48176 B YU 48176B YU 119491 A YU119491 A YU 119491A YU 119491 A YU119491 A YU 119491A YU 48176 B YU48176 B YU 48176B
Authority
YU
Yugoslavia
Prior art keywords
alkyl
hydrogen
halo
6alkyl
trifluoromethyl
Prior art date
Application number
YU119491A
Other languages
English (en)
Other versions
YU119491A (sh
Inventor
M.J. Kukla
H.J. Breslin
A.H.M. Raeymaekers
J.L.H. Van Gelder
P.A.J. Janssen
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of YU119491A publication Critical patent/YU119491A/sh
Publication of YU48176B publication Critical patent/YU48176B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

NOVI TETRAHIDROIMIDAZO [1,4] BENZODIAZEPIN-2-(TI)ONI I POSTUPAK NJIHOVOG DOBIJANJA - Jedinjenje formule: i njegova farmaceutski prihvatljiva kiselinska adiciona so i njegov stereohemijski izomerni oblik, u kojoj:X je O ili S; R1 je radikal formule: Alk je C1-6alkandiil; R6 je vodonik, halo ili C1-4alkil; R7 i R8 svaki nezavisno su vodonik, halo, C3-6cikloalkil, trifluorometil, 2,2,2-trifluoroetil, C1-4alkil, koji je u datom primeru supstituisan sa C1-4alkoksi; R9 je vodonik, halo ili C1-4alkil; svaki R10 je nezavisno vodonik ili C1-4alkil ili oba R10uzeta zajedno mogu da obrazuju C1-6alkandiilni radikal; n je 2,3,4,5 ili 6; R11 je vodonik ili C2-6alkenil; svaki R12 je nezavisno vodonik ili C1-4alkil ili oba R12 uzeta zajedno mogu da obrazuju C1-6alkandiil radikal; m je 0,1 ili 2; R13 je C1-6alkil, aril, arilmetil, C3-6cikloalkil ili (C3-6cik-loalkil)C1-4alkil; R2 je vodonik ili C1-6alkil; R3 je vodonik ili C1-6alkil; R4 i R5 svaki nezavisno su vodonik, C1-6alkil, halo, cijano, nitro, trifluorometil, hidroksi, C1-6alkiloksi, amino, mono- ili di(C1-6alkil)amino, C1-6alkilkarbonilamino ili arilkar-bonilamino i svaki aril je fenil koji je u datom primeru supstituisan sa 1 do 3 supstituenata nezavisno odabranih izmed-ju C1-6alkila, halo, hidroksi, C1-6alkoksi, amino, nitro i tri-fluorometila; pod uslovom da kada su R4 i R5 različiti od C1-6alkilkarbonilamino ili arilkarbonilamino, tada je R1 različiti od C3-6alkenila i (C3-6cikloalkil)C1-6alkila. - Prijava sadrži još 1 nezavisan i 5 zavisnih zahteva.
YU119491A 1990-07-06 1991-07-05 Novi tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja YU48176B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54934990A 1990-07-06 1990-07-06

Publications (2)

Publication Number Publication Date
YU119491A YU119491A (sh) 1994-06-10
YU48176B true YU48176B (sh) 1997-07-31

Family

ID=24192641

Family Applications (1)

Application Number Title Priority Date Filing Date
YU119491A YU48176B (sh) 1990-07-06 1991-07-05 Novi tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja

Country Status (29)

Country Link
EP (1) EP0538297B9 (sh)
JP (1) JPH05508632A (sh)
CN (1) CN1034122C (sh)
AP (1) AP262A (sh)
AT (1) ATE205848T1 (sh)
AU (1) AU644192B2 (sh)
CA (1) CA2086547A1 (sh)
CZ (1) CZ279900B6 (sh)
DE (1) DE69132738T2 (sh)
DK (1) DK0538297T3 (sh)
ES (1) ES2164044T3 (sh)
FI (1) FI930024A0 (sh)
HU (1) HUT68382A (sh)
IE (1) IE912363A1 (sh)
IL (1) IL98726A (sh)
MA (1) MA22205A1 (sh)
MX (1) MX9100103A (sh)
MY (1) MY106786A (sh)
NO (1) NO300420B1 (sh)
NZ (1) NZ238664A (sh)
OA (1) OA09769A (sh)
PL (3) PL168320B1 (sh)
PT (1) PT98225B (sh)
SK (1) SK278442B6 (sh)
TN (1) TNSN91055A1 (sh)
TW (1) TW211014B (sh)
WO (1) WO1992000979A1 (sh)
YU (1) YU48176B (sh)
ZA (1) ZA915239B (sh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184787T1 (de) * 1992-05-13 1999-10-15 Wellcome Found Therapeutische kombinationen
US6177435B1 (en) 1992-05-13 2001-01-23 Glaxo Wellcome Inc. Therapeutic combinations
US5519021A (en) * 1992-08-07 1996-05-21 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
US6420357B1 (en) 1997-12-23 2002-07-16 Instituto Biomar, S.A. Cytotoxic alkaloid derivatives including Asmarine A and B isolated from a sponge

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8806449D0 (en) * 1988-03-18 1988-04-20 Janssen Pharmaceutica Nv Antiviral hexahydroimiazo(1 4)benzodiazepin-2-ones
IL93136A (en) * 1989-02-23 1995-01-24 Janssen Pharmaceutica Nv History of tetrahydroimidazo [1,4] benzodiazepine-2-thione, their preparation and pharmaceutical preparations containing them
NZ235137A (en) * 1989-09-13 1992-02-25 Janssen Pharmaceutica Nv Tetrahydroimidazo(1,4)benzodiazepine derivatives, preparation and pharmaceutical compositions thereof
DE4036552C1 (sh) * 1990-11-16 1992-02-06 Boehringer Mannheim Gmbh, 6800 Mannheim, De

Also Published As

Publication number Publication date
ATE205848T1 (de) 2001-10-15
AU8068391A (en) 1992-02-04
PT98225B (pt) 1998-12-31
WO1992000979A1 (en) 1992-01-23
CS206591A3 (en) 1992-03-18
EP0538297A1 (en) 1993-04-28
NO924853L (no) 1992-12-15
PL169662B1 (en) 1996-08-30
AU644192B2 (en) 1993-12-02
IL98726A (en) 1996-01-31
ZA915239B (en) 1993-03-31
MY106786A (en) 1995-07-31
DK0538297T3 (da) 2001-12-27
YU119491A (sh) 1994-06-10
CN1057840A (zh) 1992-01-15
CZ279900B6 (cs) 1995-08-16
FI930024A (fi) 1993-01-05
JPH05508632A (ja) 1993-12-02
AP9100289A0 (en) 1991-07-31
HU9300011D0 (en) 1993-04-28
FI930024A0 (fi) 1993-01-05
PL297379A1 (sh) 1992-07-13
IE912363A1 (en) 1992-01-15
MX9100103A (es) 1992-02-28
HUT68382A (en) 1995-06-28
TNSN91055A1 (fr) 1992-10-25
SK278442B6 (en) 1997-05-07
EP0538297B1 (en) 2001-09-19
PL169613B1 (pl) 1996-08-30
CA2086547A1 (en) 1992-01-07
NZ238664A (en) 1992-12-23
DE69132738T2 (de) 2002-07-04
MA22205A1 (fr) 1992-04-01
PT98225A (pt) 1992-05-29
ES2164044T3 (es) 2002-02-16
TW211014B (sh) 1993-08-11
AP262A (en) 1993-06-03
CN1034122C (zh) 1997-02-26
OA09769A (fr) 1993-11-30
PL168320B1 (pl) 1996-02-29
EP0538297B9 (en) 2002-10-16
IL98726A0 (en) 1992-07-15
NO300420B1 (no) 1997-05-26
DE69132738D1 (de) 2001-10-25
NO924853D0 (no) 1992-12-15

Similar Documents

Publication Publication Date Title
TW229140B (sh)
YU48105B (sh) Derivati triazola i postupak za njihovo dobijanje
BR9611618A (pt) Composto processo para sua preparação composição farmacêutica e utilização de um compostos
AU538928B2 (en) Substituted propenylamine derivatives
GB1088531A (en) Substituted benzamides
TW234116B (en) 2-Cyano-3-hydroxy-enamides and their preparation process
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
MY114679A (en) Aroyl-piperidine derivatives
GB1189064A (en) Indole Derivatives
ES8801833A1 (es) Un procedimiento para la preparacion de un compuesto.
ES477832A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano.
NZ227436A (en) Cell proliferation inhibiting composition comprising a substituted styrene derivative
BG102858A (en) Pyrasol compounds, methods for their preparation and herbicides containing them
ES8609204A1 (es) Procedimiento de preparar derivados aminicos
YU47219B (sh) Antivirusna tetrahidroimidazo (1,4) benzodiazepin-2-tiona jedinjenja i postupak za njihovo dobijanje
ES2019163A6 (es) Procedimiento para preparar derivados de imidazol.
YU48176B (sh) Novi tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja
MY131762A (en) Pharmaceutical compounds
ES8202000A1 (es) Procedimiento para preparar pirimidil-quinazolinas
MY103502A (en) Novel compounds
ES8301971A1 (es) Un proceso para la preparacion de derivados de n-alquilimi- dazoles sustituidos
MY131141A (en) N-benzyl-indoles, processes for their preparation and pharmaceutical compositions containing them.
ES8300095A1 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES8201979A1 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
ES8607910A1 (es) Un procedimiento para la preparacion de nuevos derivados de feniletanamina